Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...

Recent advances in the field of immunology suggest that innate immune cells (e.g. dendritic cells, NK cells, phagocytes) are capable of displaying a form of ...

Poor physical performance in patients with non-Hodgkin lymphoma receiving CAR T-cell therapy was linked to worse survival and ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

Mitochondrial stress disrupts insulin production in diabetes, but reversing the damage may restore β-cell function.

The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their ...

TG Therapeutics will use MaxCyte’s technology to advance toward a clinical trial its azer-cel CAR T-cell therapy for ...

Fibrosis is a pathological process characterized by excessive deposition of extracellular matrix (ECM) components, leading to tissue scarring and organ ...